Abstract
The first review regarding the potential of aurones as promising drug candidates was reported in 2003. Since, considerable efforts have been made to explore the pharmacological and therapeutical activities of aurones. In this regard, many biological areas were concerned, including major pathological, such as cancer and neurodegenerative disorders. The aim of the present report is to highlight the progress made during the last ten years on the medicinal chemistry of aurones. A special focus will be made on the structure-activity relationship aspects among aurones and especially in case where aurones were found highly active than the corresponding flavones and chalcones.
Keywords: Alzheimer’s disease, antioxidants, aureusidin, antiviral, aurones, cancer, cytotoxicity, flavonoids, hepatitis C, kinases, sulfuretin, tyrosinase
Current Medicinal Chemistry
Title:Recent Advances in the Medicinal Chemistry of Aurones
Volume: 19 Issue: 18
Author(s): R. Haudecoeur and A. Boumendjel
Affiliation:
Keywords: Alzheimer’s disease, antioxidants, aureusidin, antiviral, aurones, cancer, cytotoxicity, flavonoids, hepatitis C, kinases, sulfuretin, tyrosinase
Abstract: The first review regarding the potential of aurones as promising drug candidates was reported in 2003. Since, considerable efforts have been made to explore the pharmacological and therapeutical activities of aurones. In this regard, many biological areas were concerned, including major pathological, such as cancer and neurodegenerative disorders. The aim of the present report is to highlight the progress made during the last ten years on the medicinal chemistry of aurones. A special focus will be made on the structure-activity relationship aspects among aurones and especially in case where aurones were found highly active than the corresponding flavones and chalcones.
Export Options
About this article
Cite this article as:
Haudecoeur R. and Boumendjel A., Recent Advances in the Medicinal Chemistry of Aurones, Current Medicinal Chemistry 2012; 19 (18) . https://dx.doi.org/10.2174/092986712800672085
DOI https://dx.doi.org/10.2174/092986712800672085 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Trends and Advances in Oral and Maxillofacial Imaging
Current Medical Imaging Mechanisms of Mononuclear Phagocyte Recruitment in Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Melatonin Attenuates Methamphetamine-Induced Neurotoxicity
Current Pharmaceutical Design In Vitro Modeling of the Blood-Brain Barrier: Simplicity Versus Complexity
Current Pharmaceutical Design CCL2-CCR2 Signaling in Disease Pathogenesis
Endocrine, Metabolic & Immune Disorders - Drug Targets Metal-Score as a Potential Non-Invasive Diagnostic Test for Alzheimer’s Disease
Current Alzheimer Research Parkinson´s and Alzheimer´s Diseases and Natural Products: Pathologies and Medication of the New Times
Current Neuropharmacology Discovery of Novel CK2 Leads by Cross-Docking Based Virtual Screening
Medicinal Chemistry Meet Our Editorial Board Member
Current Psychiatry Reviews Adipose Tissue Derived Stem Cells Secretome: Soluble Factors and Their Roles in Regenerative Medicine
Current Stem Cell Research & Therapy Small Molecule Natural Products and Alzheimer’s Disease
Current Topics in Medicinal Chemistry Peripheral Immune Signatures in Alzheimer Disease
Current Alzheimer Research Annexins in the Central Nervous System: Are they Neuroprotective or Proapoptotic Agents?
Medicinal Chemistry Reviews - Online (Discontinued) Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer’s Disease
Current Neuropharmacology Molecular Insight into the Crosstalk of UPS Components and Alzheimer’s Disease
Current Protein & Peptide Science The Renin-Angiotensin System in the Mammalian Central Nervous System
Current Protein & Peptide Science GSK3 Inhibitors and Disease
Mini-Reviews in Medicinal Chemistry Macrophage Colony-Stimulating Factor (M-CSF) in Plasma and CSF of Patients with Mild Cognitive Impairment and Alzheimers Disease
Current Alzheimer Research Oxidative Imbalance and Anxiety Disorders
Current Neuropharmacology Meet the Editorial Board:
Technology Transfer and Entrepreneurship (Discontinued)